BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang LH, Wang Z, Li LH, Liu YK, Jin LF, Qi XW, Zhang C, Wang T, Hua D. Vestigial like family member 3 is a novel prognostic biomarker for gastric cancer. World J Clin Cases 2019; 7(15): 1954-1963 [PMID: 31423427 DOI: 10.12998/wjcc.v7.i15.1954]
URL: https://www.wjgnet.com/2307-8960/full/v7/i15/1954.htm
Number Citing Articles
1
Ziheng Wang, Xinqi Ge, Jinlong Shi, Bing Lu, Xiaojin Zhang, Jianfei Huang, wenjie shi. SPTSSA Is a Prognostic Marker for Glioblastoma Associated with Tumor-Infiltrating Immune Cells and Oxidative StressOxidative Medicine and Cellular Longevity 2022; 2022: 1 doi: 10.1155/2022/6711085
2
Maxime Liberelle, Florine Toulotte, Nicolas Renault, Muriel Gelin, Frédéric Allemand, Patricia Melnyk, Jean-François Guichou, Philippe Cotelle. Toward the Design of Ligands Selective for the C-Terminal Domain of TEADsJournal of Medicinal Chemistry 2022; 65(8): 5926 doi: 10.1021/acs.jmedchem.2c00075
3
Joo-Young Im, Da-Mi Kim, Hyunkyung Park, Mi-Jung Kang, Da-Yoon Kim, Kwan Young Chang, Bo-Kyung Kim, Misun Won. VGLL1 phosphorylation and activation promotes gastric cancer malignancy via TGF-β/ERK/RSK2 signalingBiochimica et Biophysica Acta (BBA) - Molecular Cell Research 2021; 1868(1): 118892 doi: 10.1016/j.bbamcr.2020.118892
4
Xinyue Qin, Yinhao Chen, Shuo Ma, Lei Shen, Shaoqing Ju. Immune‐related gene TM4SF18 could promote the metastasis of gastric cancer cells and predict the prognosis of gastric cancer patientsMolecular Oncology 2022; 16(22): 4043 doi: 10.1002/1878-0261.13321
5
Shuo Ma, Xinliang Gu, Lei Shen, Yinhao Chen, Chen Qian, Xianjuan Shen, Shaoqing Ju. CircHAS2 promotes the proliferation, migration, and invasion of gastric cancer cells by regulating PPM1E mediated by hsa-miR-944Cell Death & Disease 2021; 12(10) doi: 10.1038/s41419-021-04158-w
6
Naoto Hori, Kazuyuki Okada, Yuki Takakura, Hiroyuki Takano, Naoto Yamaguchi, Noritaka Yamaguchi. Vestigial-like family member 3 (VGLL3), a cofactor for TEAD transcription factors, promotes cancer cell proliferation by activating the Hippo pathwayJournal of Biological Chemistry 2020; 295(26): 8798 doi: 10.1074/jbc.RA120.012781
7
Shuai Deng, Bin Gu, Zheng Yu, Zhen Shen, Houwei Ren. MIR210HG Aggravates Sepsis-Induced Inflammatory Response of Proximal Tubular Epithelial Cell via the NF-κB Signaling PathwayYonsei Medical Journal 2021; 62(5): 461 doi: 10.3349/ymj.2021.62.5.461
8
Razaul Haque, Jaebon Lee, Joon-Yong Chung, Ha-Yeon Shin, Hyosun Kim, Jae-Hoon Kim, Jae Won Yun, Eun-Suk Kang. VGLL3 expression is associated with macrophage infiltration and predicts poor prognosis in epithelial ovarian cancerFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1152991
9
Yit Khee Wong, Weng Howe Chan, Hui Wen Nies, Kohbalan A-L Moorthy. Multi-stage Feature Selection in Identifying Potential Biomarkers for Cancer Classification2022 2nd International Conference on Intelligent Cybernetics Technology & Applications (ICICyTA) 2022; : 6 doi: 10.1109/ICICyTA57421.2022.10037807
10
Manon Sturbaut, Fabrice Bailly, Mathilde Coevoet, Pasquale Sileo, Martine Pugniere, Maxime Liberelle, Romain Magnez, Xavier Thuru, Marie-Christine Chartier-Harlin, Patricia Melnyk, Muriel Gelin, Frédéric Allemand, Jean-François Guichou, Philippe Cotelle. Discovery of a cryptic site at the interface 2 of TEAD – Towards a new family of YAP/TAZ-TEAD inhibitorsEuropean Journal of Medicinal Chemistry 2021; 226: 113835 doi: 10.1016/j.ejmech.2021.113835
11
Panfeng Chen, Ping Jiang, Jianing Chen, Yang Yang, Xiumei Guo. XIST promotes apoptosis and the inflammatory response in CSE-stimulated cells via the miR-200c-3p/EGR3 axisBMC Pulmonary Medicine 2021; 21(1) doi: 10.1186/s12890-021-01582-8
12
Benjamin Zagiel, Patricia Melnyk, Philippe Cotelle. Progress with YAP/TAZ-TEAD inhibitors: a patent review (2018-present)Expert Opinion on Therapeutic Patents 2022; 32(8): 899 doi: 10.1080/13543776.2022.2096436
13
Li-Hua Zhang, Yan Wang, Qian-Qian Fan, Yan-Kui Liu, Long-Hai Li, Xiao-Wei Qi, Yong Mao, Dong Hua. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancerWorld Journal of Gastroenterology 2019; 25(38): 5814-5825 doi: 10.3748/wjg.v25.i38.5814
14
Lihua Zhang, Longhai Li, Yong Mao, Dong Hua. VGLL3 is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in stomach adenocarcinomaScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-58493-7
15
Hu Song, Yixin Xu, Teng Xu, Ruizhi Fan, Tao Jiang, Meng Cao, Linseng Shi, Jun Song. CircPIP5K1A activates KRT80 and PI3K/AKT pathway to promote gastric cancer development through sponging miR-671-5pBiomedicine & Pharmacotherapy 2020; 126: 109941 doi: 10.1016/j.biopha.2020.109941
16
Noritaka Yamaguchi. Multiple Roles of Vestigial-Like Family Members in Tumor DevelopmentFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01266
17
Tomohiro Kawamura, Yuki Takehora, Naoto Hori, Yuki Takakura, Naoto Yamaguchi, Hiroyuki Takano, Noritaka Yamaguchi. VGLL3 increases the dependency of cancer cells on de novo nucleotide synthesis through GART expressionJournal of Cellular Biochemistry 2022; 123(6): 1064 doi: 10.1002/jcb.30251